Previous 10 | Next 10 |
Citius Pharmaceuticals is a late-stage biopharma focused on critical care products. Preventing shareholder dilution. Resumption of clinical trials after COVID-19. For further details see: Critical Care Biopharma - Citius Pharmaceuticals
Citius Pharmaceuticals Announces Key Management Realignment to Support Commercialization of Two Late-Stage Product Candidates PR Newswire Leonard Mazur named Chairman of the Board of Directors and CEO of Citius Citius co-founder, Myron Holubiak to trans...
Buying Penny Stocks Today? Here’s What You Need to Know With another day of trading penny stocks here, there is a lot for investors to understand. While investing can be complicated at times, understanding exactly what is going on in the stock market is a crucial step to making...
Tufin Software Technologies (TUFN) +43% on report of $570M bid Turn/River Capital. Mobiquity Technologies (OTCQB:MOBQ) +31% partners with a-nation to provide data and programmatic advertising. BigBear.ai Holdings (BBAI) +29%. Citius Pharmaceuticals (CTXR) +17% as I/ON...
Citius Pharmaceuticals (NASDAQ:CTXR) said a phase 3 trial of its drug I/ONTAK, a new formulation of a discontinued drug ONTAK, showed the therapy to be consistent with the prior formulation to treat patients with persistent or recurrent cutaneous T-cell lymphoma (CTCL). The company...
Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy I/ONTAK (E7777) for the Treatment of Persistent or Recurrent Cutaneous T-Cell Lymphoma (CTCL) in Support of BLA Submission PR Newswire CRANFORD, N.J. , April 6,...
5 Active Programs With Near Term Catalysts. I/ONTEK Topline Data Release Expected As Early As April. Price Target of $10. For further details see: Citius: 2022 Is A Year Of Catalysts
3 Biotech Penny Stocks to Watch in March 2022 Buying penny stocks be a great investment opportunity, but it’s important to understand the risks before you invest. With so many penny stocks to choose from, it can be difficult to find the best ones to buy. And when it comes to ...
Citius Pharmaceuticals, Inc. to Present at Upcoming March 2022 Conferences 34th Annual ROTH Conference March 13-15, 2022 Maxim's 2022 Virtual Growth Conference March 28-30, 2022 PR Newswire CRANFORD, N.J. , March 3, 2022 /PRNewswire/ -- Citius Pharmaceuti...
The Ukraine-Russia crisis continues heating up, which has profoundly impacted everything, including penny stocks. Today more updates on Russia and Ukraine surfaced, citing a “pro-Russian” attack on a border village. Meanwhile, Russian-controlled media outlet RIA said that Ukra...
News, Short Squeeze, Breakout and More Instantly...
Citius Pharmaceuticals Inc. Company Name:
CTXR Stock Symbol:
NASDAQ Market:
Citius Pharmaceuticals Inc. Website:
2024-07-18 10:20:00 ET July 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compa...
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 18, 2024) - Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. (NASDAQ: CTXR), a late-stage biopharmaceutical c...
2024-07-17 10:10:00 ET July 17, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compan...